Learning Objectives:

1.  Evaluate the recent updates from ASCO 2021 on the treatment of NSCLC stage IV

2.  Review recent updates from ASCO 2021 on the use of (neo)adjuvant therapies for resectable NSCLC

3. Learn the recent update from PACIFC and other trials for unresectable stage III NSCLC 


Session date: 
07/08/2021 - 4:00pm to 5:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Everett Vokes MD; Marina Garassino MD; Jessica Donington MD